EP Patent

EP2819998B1 — Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1h-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1h-indazol-5-yloxy)benzyl)urea hydrochloride

Assigned to Array Biopharma Inc · Expires 2022-04-06 · 4y expired

What this patent protects

Patent listed against asenapine-maleate.

Drugs covered by this patent

asenapine-maleate (ASENAPINE MALEATE)

Patent Metadata

Patent number: EP2819998B1
Jurisdiction: EP
Classification: —
Expires: 2022-04-06
Drug substance claim: No
Drug product claim: No
Assignee: Array Biopharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.